N. Reichenbach

发表

R. Suhadolnik, N. Reichenbach, 2000 .

miR-98 reduces endothelial dysfunction by protecting blood–brain barrier (BBB) and improves neurological outcomes in mouse ischemia/reperfusion stroke model

S. Rom, B. Polyak, Y. Persidsky, 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Effects of electronic nicotine delivery systems and cigarettes on systemic circulation and blood brain barrier: implications for cognitive decline.

Y. Persidsky, N. Reichenbach, N. A. Heldt, 2020, The American journal of pathology.

Electronic cigarette exposure disrupts blood-brain barrier integrity and promotes neuroinflammation

B. Gregory, Xiang Yu, Y. Persidsky, 2020, Brain, Behavior, and Immunity.

Biochemical Dysregulation of the 2-5A Synthetase/RNase L Antiviral Defense Pathway in Chronic Fatigue Syndrome

W. Pfleiderer, R. Charubala, P. Cheney, 1999 .

Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome.

M. Adelson, N. Kon, W. Pfleiderer, 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.

W. Müller, D. Strayer, H. Schröder, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Combination of HIV-1 and Diabetes Enhances Blood Brain Barrier Injury via Effects on Brain Endothelium and Pericytes

Y. Persidsky, Sachin Gajghate, N. Reichenbach, 2020, International journal of molecular sciences.

Dysfunction of brain pericytes in chronic neuroinflammation

A. Mukherjee, S. Ramirez, Y. Persidsky, 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5AN6B

T. Rogers, W. Pfleiderer, R. Charubala, 2002 .

CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL EFFECTS OF AMPLIGEN, A MISMATCHED DOUBLE-STRANDED RNA, IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

D. Montefiori, D. Volsky, K. Karikó, 1987, The Lancet.

Poly(ADP-ribose) Polymerase-1 Inhibition in Brain Endothelium Protects the Blood—Brain Barrier under Physiologic and Neuroinflammatory Conditions

S. Ramirez, Y. Persidsky, N. Reichenbach, 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Inhibition of HIV-1 replication in CD4 + and CD14 + cells purified from HIV-1-infected individuals by the 2-5A agonist immunomodulator, 2-5A N6B

Robert, J. Gaughan, B. Suh, 2007 .

Glycogen synthase kinase 3β inhibition prevents monocyte migration across brain endothelial cells via Rac1-GTPase suppression and down-regulation of active integrin conformation.

S. Ramirez, Y. Persidsky, Shongshan Fan, 2012, The American journal of pathology.

Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.

R. Tuma, A. Mercer, S. Ramirez, 2010, The American journal of pathology.

Neurobiology Glycogen Synthase Kinase 3 Inhibition Prevents Monocyte Migration across Brain Endothelial Cells via Rac 1-GTPase Suppression and Down-Regulation of Active Integrin Conformation

S. Ramirez, Y. Persidsky, Shongshan Fan, 2012 .

Attenuation of HIV‐1 replication in macrophages by cannabinoid receptor 2 agonists

Xu Wang, W. Ho, S. Ramirez, 2013, Journal of leukocyte biology.

Inhibition of Glycogen Synthase Kinase 3β Promotes Tight Junction Stability in Brain Endothelial Cells by Half-Life Extension of Occludin and Claudin-5

A. Mercer, S. Ramirez, Y. Persidsky, 2013, PloS one.

PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier

P. Pacher, Y. Persidsky, Sachin Gajghate, 2016, Journal of Neuroinflammation.

The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity

Y. Persidsky, N. Reichenbach, Holly Dykstra, 2015, Front. Microbiol..

Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation

K. Jordan-Sciutto, Y. Persidsky, M. Erickson, 2018, Journal of Neuroinflammation.

Dyad of CD40/CD40 Ligand Fosters Neuroinflammation at the Blood–Brain Barrier and Is Regulated via JNK Signaling: Implications for HIV-1 Encephalitis

L. Del Valle, S. Maggirwar, R. Phipps, 2010, The Journal of Neuroscience.

2- and 8-azido photoaffinity probes. 1. Enzymatic synthesis, characterization, and biological properties of 2- and 8-azido photoprobes of 2-5A and photolabeling of 2-5A binding proteins.

K. Karikó, R. Sobol, B. Haley, 1988, Biochemistry.

Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.

D. Montefiori, W. Robinson, R. Sobol, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles

Y. Persidsky, Sachin Gajghate, N. Reichenbach, 2020, Scientific Reports.

Inhibition of HIV-1 Replication and Activation of RNase L by Phosphorothioate/Phosphodiester 2′,5′-Oligoadenylate Derivatives (*)

E. Mordechai, N. Kon, R. Sobol, 1995, The Journal of Biological Chemistry.

HIV-1 reverse transcriptase: inhibition by 2',5'-oligoadenylates.

Samuel H. Wilson, A. Kumar, W. Beard, 1993, Biochemistry.

Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B).

J. Gaughan, B. Suh, Xiaowei Yang, 2007, AIDS research and human retroviruses.

Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny.

Xiaowei Yang, T. Rogers, R. Sutton, 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Structural and functional features of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syndrome.

B. Lebleu, W. Pfleiderer, R. Charubala, 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

A 37-kDa RNase L: A Novel Form of RNase L Associated with Chronic Fatigue Syndrome

C. Martinand-Mari, R. Suhadolnik, N. Reichenbach, 2002 .

Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease.

K. Karikó, R. Sobol, W. Pfleiderer, 1987, Biochemistry.

Glutamate as the common precursor for the aglycon of the naturally occurring C-nucleoside antibiotics.

R. Suhadolnik, N. Reichenbach, 1981, Biochemistry.

Enzymatic synthesis of the 2',5'-A4 tetramer analog, 2',5'-ppp3'dA(p3'dA)3, by rabbit reticulocyte lysates: binding and activation of the 2',5'-A eta dependent nuclease, hydrolysis of mRNA, and inhibition of protein synthesis.

J. Wu, M. Flick, R. Suhadolnik, 1983, Biochemical and biophysical research communications.

Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.

J. Mosca, P. Doetsch, W. Pfleiderer, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Accumulation of low molecular weight DNA and changes in chromatin structure in HeLa cells treated with human fibroblast interferon.

E. Henderson, R. Suhadolnik, N. Reichenbach, 1984, The Journal of biological chemistry.

Enzymic synthesis of (2'-5')ppp3'dA(p3'dA)n, the cordycepin analog of (2'-5')-oligoadenylic acid.

J. Mosca, P. Doetsch, J. Wu, 1981, Methods in enzymology.

Phosphorothioate Analogs of 2–5A: Elucidation of the Stereochemical Course of the Enzymes of the 2–5A Synthetase/RNase L System

K. Karikó, R. Sobol, W. Pfleiderer, 1987 .

Cordycepin Analogs of 2–5 a as Activators of RNase L: Study of the Structural Requirements for RNase L Activation

K. Karikó, W. Pfleiderer, R. Charubala, 1987 .

Phosphorothioate Analogs OF 2-5A: Activation / Inhibition of Rnase L and Inhibition of HIV-1 Reverse Transcriftase

D. Montefiori, B. Lebleu, K. Karikó, 1989 .

Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier.

P. Pacher, Y. Persidsky, N. Reichenbach, 2013, The American journal of pathology.

Author Correction: Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles

Y. Persidsky, Sachin Gajghate, N. Reichenbach, 2020, Scientific Reports.

PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier

P. Pacher, Y. Persidsky, Sachin Gajghate, 2016, Journal of Neuroinflammation.

Decreased Epstein-Barr virus-induced transformation, and elevated 2-5A synthetase and RNase L activity in peripheral blood mononuclear cells from patients treated with recombinant interferon alfa 2b.

E. Vonderheid, K. Karikó, K. Chavin, 1988, Biochemical and biophysical research communications.

Methamphetamine Disrupts Blood–Brain Barrier Function by Induction of Oxidative Stress in Brain Endothelial Cells

P. Couraud, I. Romero, B. Weksler, 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Activation of Cannabinoid Receptor 2 Attenuates Leukocyte–Endothelial Cell Interactions and Blood–Brain Barrier Dysfunction under Inflammatory Conditions

I. Krizbai, R. Tuma, A. Mahadevan, 2012, The Journal of Neuroscience.

let-7g counteracts endothelial dysfunction and ameliorating neurological functions in mouse ischemia/reperfusion stroke model

Y. Persidsky, Sachin Gajghate, N. Reichenbach, 2020, Brain, Behavior, and Immunity.

Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway

J. Gaughan, J. Gabriel, N. McGregor, 2004 .

Ampligen inhibits human herpesvirus-6 in vitro.

A. Komaroff, Z. Berneman, D. Strayer, 1994, In vivo.

Characterization of human fetal brain endothelial cells reveals barrier properties suitable for in vitro modeling of the BBB with syngenic co-cultures

A. Andrews, D. Langford, S. Ramirez, 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

miR-98 and let-7g* Protect the Blood-Brain Barrier Under Neuroinflammatory Conditions

Y. Persidsky, N. Reichenbach, Viviana Zuluaga-Ramirez, 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Plant oligoadenylates: enzymatic synthesis, isolation, and biological activities.

M. Reichman, R. Suhadolnik, N. Reichenbach, 1985, Biochemistry.

Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium

S. Ramirez, Y. Persidsky, Shongshan Fan, 2015, Journal of Neuroimmune Pharmacology.

Heroin Use Promotes HCV Infection and Dysregulates HCV-Related Circulating microRNAs

Xu Wang, D. Zhou, W. Ho, 2015, Journal of Neuroimmune Pharmacology.

Inhibition of growth of estrogen receptor positive and estrogen receptor negative breast cancer cells in culture by AA-etherA, a stable 2-5A derivative.

M. Adelson, E. Mordechai, K. Latham, 1996, Oncogene.

Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B).

T. Rogers, W. Pfleiderer, R. Charubala, 2002, Journal of acquired immune deficiency syndromes.

Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation

K. Jordan-Sciutto, Y. Persidsky, M. Erickson, 2018, Journal of Neuroinflammation.

Author Correction: Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles

Y. Persidsky, Sachin Gajghate, N. Reichenbach, 2020, Scientific Reports.

Poly(ADP-ribose) polymerase activity in HeLa cells treated with various antibiotics.

R. Suhadolnik, N. Reichenbach, Y. Sawada, 1982, The Journal of antibiotics.

Heroin Use Promotes HCV Infection and Dysregulates HCV-Related Circulating microRNAs

Xu Wang, D. Zhou, W. Ho, 2015, Journal of Neuroimmune Pharmacology.

Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium

S. Ramirez, Y. Persidsky, Shongshan Fan, 2015, Journal of Neuroimmune Pharmacology.

Nevada Chronic Fatigue Syndrome Consensus Conference

R. Armitage, P. Levine, N. Klimas, 2001 .

Attenuation of HIV‐1 replication in macrophages by cannabinoid receptor 2 agonists

Xu Wang, W. Ho, S. Ramirez, 2013, Journal of leukocyte biology.

RNA Drug Therapy Acting via the 2–5A Synthetase/RNase L Pathway

D. Strayer, D. Ablashi, W. Carter, 1993, Annals of the New York Academy of Sciences.

Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.

M. Loveless, M. Adelson, W. Müller, 1994, In vivo.